Gates-backed TB drug to enter late-stage testing
April 23, 2014 at 16:26 PM EDT
CHICAGO, April 23 (Reuters) - The first experimental drug that fights both conventional and drug-resistant forms of tuberculosis is advancing to late-stage clinical testing, researchers said on Wednesday, raising hope for a new way to stem the growing threat of drug-resistant TB.